Pharmafile Logo

World Health Organization

- PMLiVE

WHO launches R&D efforts to identify pathogens that could cause future pandemics

Over 300 scientists will convene to discuss over 25 virus and bacteria, including ‘Disease X’

- PMLiVE

European MPs call for urgent action against antimicrobial resistance

It is estimated that AMR could lead to as many as ten million deaths each year by 2050

- PMLiVE

World Antimicrobial Awareness Week 2022

Reports from the World Health Organization show that AMR is one of the top ten threats to global health

- PMLiVE

WHO, WIPO and WTO to hold technical symposium on pandemic preparedness

The event will examine ways to build resilience to be better prepared for future pandemics

- PMLiVE

Act-Accelerator outlines plans for longterm COVID-19 control

Its plan highlights key priorities as countries transition to manage the public health issue

- PMLiVE

WHO reveals tuberculosis deaths rose due to COVID-19 disruption

An estimated 10.6 million were infected with TB in 2021, an increase of 4.5% from 2020

- PMLiVE

WHO publishes first-ever fungal priority pathogens list in face of antimicrobial resistance

The list highlights the public health threat presented by fungal infections on a global scale

- PMLiVE

Merck to donate Sudan Ebola virus vaccine to International AIDS Vaccine Initiative

Around 50,000 doses are expected to be provided for further clinical research use

- PMLiVE

WHO partners with IANPHI to strengthen health emergency preparedness

The two organisations will work together to enhance national public health capacities

- PMLiVE

Global leaders pledge $2.6bn at World Health Summit in efforts to end polio

The pledging moment was a milestone in fulfilling the $4.8bn required to implement the GPEI Strategy

- PMLiVE

WHO unveils AI-powered digital health worker, Florence 2.0

The chatbot builds on its previous version, which was used to tackle COVID-19 misinformation

- PMLiVE

WHO unveils new initiative to halt spread of invasive malaria vector in Africa

Anopheles stephensi thrives in urban settings, where 40% of the population in Africa live

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links